FDA Approved: ERAXIS — Supplemental Application (Roerig)

View source ↗

Summary

FDA approved a supplemental application for ERAXIS (anidulafungin) submitted by Roerig to update/expand the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Esophageal Candidiasis
• Invasive Candidiasis

Drugs mentioned

• Eraxis (anidulafungin)

Snippet

SUPPL AP for ERAXIS (ANIDULAFUNGIN)